Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 1995 Jul; 13(7):1589-99.

View in: PubMed

subject areas

Adult
Age Factors
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Cause of Death
Cisplatin
Cyclophosphamide
Disease Progression
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
Prognosis
Prospective Studies
Reoperation

authors with profiles

William Thomas Creasman